Titration when switching from insulin degludec to insulin glargine U300 among Japanese diabetes patients

被引：0
|
作者：
Ishikawa, Takuya [1 ,2 ]
Kato, Tomotaka [1 ]
Iijima, Yasuhiro [1 ]
Sakurai, Mamoru [1 ]
Shikuma, Jumpei [1 ]
Ito, Rokuro [1 ]
Sakai, Hiroyuki [1 ]
Hara, Kazuo [1 ]
Miwa, Takashi [1 ]
Kanazawa, Akira [1 ]
Odawara, Masato [1 ]
机构：
[1] Tokyo Med Univ, Dept Diabet Endocrinol Metab & Rheumatol, Div Endocrinol Diabet & Metab, Tokyo, Japan
[2] Toda Chuo Gen Hosp, Dept Internal Med, Saitama, Japan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2016年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PD-56
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [1] Effects of Switching from Degludec to Glargine U300 in Patients with Insulin-Dependent Type 1 Diabetes: A Retrospective Study
    Sawamura, Toshitaka
    Karashima, Shigehiro
    Ohbatake, Azusa
    Higashitani, Takuya
    Ohmori, Ai
    Sawada, Kei
    Yamamoto, Rika
    Kometani, Mitsuhiro
    Katsuda, Yuko
    Yoneda, Takashi
    [J]. MEDICINA-LITHUANIA, 2024, 60 (03):
  • [2] CONFIRM: a comparative effectiveness study of insulin degludec and insulin glargine 300 units/ ml (glargine U300) in insulin-naive patients with type 2 diabetes
    Tibaldi, J.
    Haldrup, S.
    Sandberg, V.
    Wolden, M. L.
    Rodbard, H. W.
    [J]. DIABETOLOGIA, 2018, 61 : S44 - S44
  • [3] Insulin doses requirements in patients with type 1 diabetes using glargine U300 or degludec in routine clinical practice
    Carral San Laureano, Florentino
    Tome Fernandez-Ladreda, Mariana
    Jimenez Millan, Ana Isabel
    Garcia Calzado, Concepcion
    Ayala Ortega, Maria del Carmen
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (05) : 983 - 988
  • [4] Insulin of glargine U300 - a Basal Insulin in the next Generation
    Luger, A.
    [J]. AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2015, 8 (02): : 66 - 68
  • [5] Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U300 in the Netherlands: Evidence From a Randomised Controlled Trial
    Marc Evans
    Robert G. J. Moes
    Katrine S. Pedersen
    Jens Gundgaard
    Thomas R. Pieber
    [J]. Advances in Therapy, 2020, 37 : 2413 - 2426
  • [6] Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U300 in the Netherlands: Evidence From a Randomised Controlled Trial
    Evans, Marc
    Moes, Robert G. J.
    Pedersen, Katrine S.
    Gundgaard, Jens
    Pieber, Thomas R.
    [J]. ADVANCES IN THERAPY, 2020, 37 (05) : 2413 - 2426
  • [7] Versatile Insulin glargine U300 in daily Practice
    不详
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2016, 25 (02): : 7 - 8
  • [8] rDNA insulin glargine U300 - a critical appraisal
    Wang, Fei
    Zassman, Stefanie
    Goldberg, Philip A.
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2016, 9 : 425 - 441
  • [9] Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
    Athena Philis-Tsimikas
    David C. Klonoff
    Kamlesh Khunti
    Harpreet S. Bajaj
    Lawrence A. Leiter
    Melissa V. Hansen
    Lone N. Troelsen
    Steen Ladelund
    Simon Heller
    Thomas R. Pieber
    [J]. Diabetologia, 2020, 63 : 698 - 710
  • [10] Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
    Philis-Tsimikas, Athena
    Klonoff, David C.
    Khunti, Kamlesh
    Bajaj, Harpreet S.
    Leiter, Lawrence A.
    Hansen, Melissa, V
    Troelsen, Lone N.
    Ladelund, Steen
    Heller, Simon
    Pieber, Thomas R.
    [J]. DIABETOLOGIA, 2020, 63 (04) : 698 - 710
12345